SCHEMBL3263344

SCHEMBL3263344

O=C(O)CCCCCCCCCCCCCC(C(=O)OC(=O)C(CCCCCCCCCCCCCC(=O)O)c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 5/20 0.51
HDAC3 O15379 2/20 0.46
HDAC4 P56524 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC7 Q8WUI4 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC10 Q969S8 2/20 0.46
HDAC11 Q96DB2 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HDAC9 Q9UKV0 2/20 0.46
HDAC5 Q9UQL6 2/20 0.46
MAPT P10636 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
TBXA2R P21731 1/20 0.43
GSTK1 Q9Y2Q3 2/20 0.42
NPSR1 Q6W5P4 1/20 0.41
MAPK1 P28482 1/20 0.41
ADRA1A P35348 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1595458 1.00 TBXAS1 (0.51) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL192371 0.86 CYP2D6 (0.44) TBXAS1NPSR1MAPK1SMN1; SMN2CYP2C19
SCHEMBL14359989 0.85 TBXAS1 (0.55) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL14360466 0.85 TBXAS1 (0.55) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6542954 0.85 TBXAS1 (0.55) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL1595937 0.85 TBXAS1 (0.55) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL14360038 0.85 TBXAS1 (0.55) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL11578611 0.84 NPC1 (0.48) SMN1; SMN2ALDH1A1TSHR
SCHEMBL14062067 0.84 NPC1 (0.48) SMN1; SMN2ALDH1A1TSHR
SCHEMBL14359835 0.83 CYP2C19 (0.53) TBXAS1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241402-B2 Organic positive temperature coefficient thermistor TDK CORPORATION (JP) 2007-07-10 US claimed
EP-1585145-A1 Organic positive temperature coefficient thermistor TDK Corporation (JP) 2005-10-12 EP claimed
WO-2024150793-A1 POLYCRYSTALLINE FORM OF BIPHENOL DIGLYCIDYL ETHER, AND RESIN COMPOSITION CONTAINING SAID POLYCRYSTALLINE FORM AND CURED PRODUCT THEREOF 三菱ケミカル株式会社 2024-07-18 WO disclosed
EP-4397492-A1 ADHESIVE, LAYERED BODY, METHOD FOR MANUFACTURING LAYERED BODY, AND PACKAGING MATERIAL DIC Corporation (JP) 2024-07-10 EP disclosed
WO-2024135713-A1 EPOXY RESIN, PRODUCTION METHOD FOR SAME, CURABLE RESIN COMPOSITION, AND CURED PRODUCT 三菱ケミカル株式会社 2024-06-27 WO disclosed
WO-2024135514-A1 TWO-PART CURABLE ADHESIVE, MULTILAYER BODY AND PACKAGE DIC株式会社 2024-06-27 WO disclosed
WO-2024070871-A1 METHOD FOR PRODUCING BISPHENOL, METHOD FOR PRODUCING EPOXY RESIN, METHOD FOR PRODUCING EPOXY RESIN CURED PRODUCT, AND BISPHENOL COMPOSITION 三菱ケミカル株式会社 2024-04-04 WO disclosed
US-20230345631-A1 PREPREG, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD JSR CORPORATION (JP) 2023-10-26 US disclosed
US-20230322653-A1 BISPHENOL PRODUCTION METHOD , RECYCLED POLYCARBONATE RESIN PRODUCTION METHOD, CARBON DIOXIDE PRODUCTION METHOD, CARBONIC ACID DIESTER PRODUCTION METHOD, EPOXY RESIN PRODUCTION METHOD, AND EPOXY RESIN CURED PRODUCT PRODUCTION METHOD MITSUBISHI CHEMICAL CORPORATION (JP) 2023-10-12 US disclosed
EP-4253356-A1 POLYCARBONATE RESIN DECOMPOSITION METHOD, BISPHENOL PRODUCTION METHOD, DIALKYL CARBONATE PRODUCTION METHOD, ALKYL ARYL CARBONATE PRODUCTION METHOD, DIARYL CARBONATE PRODUCTION METHOD, RECYCLED POLYCARBONATE RESIN PRODUCTION METHOD, EPOXY RESIN PRODUCTION METHOD, AND EPOXY RESIN CURED PRODUCT PRODUCTION METHOD Mitsubishi Chemical Corporation (JP) 2023-10-04 EP disclosed
EP-4238954-A1 BISPHENOL PRODUCTION METHOD, RECYCLED POLYCARBONATE RESIN PRODUCTION METHOD, CARBON DIOXIDE PRODUCTION METHOD, CARBONIC DIESTER PRODUCTION METHOD, EPOXY RESIN PRODUCTION METHOD, AND EPOXY RESIN CURED PRODUCT PRODUCTION METHOD Mitsubishi Chemical Corporation (JP) 2023-09-06 EP disclosed
US-20080118766-A1 MIXED POWDER FOR POWDER METALLURGY AND GREEN COMPACT USING THE SAME KABUSHIKI KAISHA KOBE SEIKO SHO(KOBE STEEL, LTD.) (JP) 2008-05-22 US disclosed
EP-1585145-B1 Organic positive temperature coefficient thermistor TDK CORP (JP) 2007-05-09 EP disclosed
EP-1652948-B1 Use of a mixed powder for powder metallurgy to produce a green compact KOBE STEEL LTD (JP) 2007-04-18 EP disclosed
EP-1754751-A1 AQUEOUS DISPERSION, COMPOSITION AND COATING AGENT FOR PAPER Kuraray Co., Ltd., Kurashiki Plant (JP) 2007-02-21 EP disclosed
US-20070024413-A1 Organic positive temperature coefficient thermistor TDK CORPORATION (JP) 2007-02-01 US disclosed
US-20060139141-A1 Thermistor TDK CORPORATION (JP) 2006-06-29 US disclosed
US-20060090594-A1 Mixed powder for powder metallurgy and green compact using the same KABUSHIKI KAISHA KOBE SEIKO SHO(KOBE STEEL, LTD.) (JP) 2006-05-04 US disclosed
EP-1652948-A1 Mixed powder for powder metallurgy and green compact using the same KABUSHIKI KAISHA KOBE SEIKO SHO (JP) 2006-05-03 EP disclosed
EP-1585145-A1 Organic positive temperature coefficient thermistor TDK Corporation (JP) 2005-10-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322653-A1 BISPHENOL PRODUCTION METHOD , RECYCLED POLYCARBONATE RESIN PRODUCTION METHOD, CARBON DIOXIDE PRODUCTION METHOD, CARBONIC ACID DIESTER PRODUCTION METHOD, EPOXY RESIN PRODUCTION METHOD, AND EPOXY RESIN CURED PRODUCT PRODUCTION METHOD FHIT, VCP, PCBP1 TBXAS1 2824/4885HDAC3 1632/4885HDAC4 2062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.